CPC C07K 7/08 (2013.01) [A61K 38/1709 (2013.01); A61K 39/0011 (2013.01); A61K 45/06 (2013.01); C07K 7/06 (2013.01); C07K 14/7051 (2013.01); C12N 5/0638 (2013.01); C12N 9/6491 (2013.01); C12Y 304/24065 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/572 (2013.01); C12N 2502/11 (2013.01)] | 20 Claims |
1. A method of eliciting an immune response in a patient who has cancer, comprising administering to the patient a composition comprising a population of activated T cells that kill the cancer cells that present a peptide consisting of the amino acid sequence RVLPPSALQSV (SEQ ID NO: 87),
wherein the activated T cells are produced by contacting T cells with an antigen presenting cell that presents the peptide in a complex with a human class I or II MHC molecule on the surface of the antigen presenting cell,
wherein said cancer is selected from non-small cell lung cancer, gastric cancer, gastrointestinal cancer, colorectal cancer, pancreatic cancer, renal cancer, prostate cancer, melanoma, glioblastoma, and bladder cancer.
|